|
Monday
|
Tuesday
|
Wednesday
|
Thursday
|
Friday
|
Saturday
|
Sunday
|
|---|---|---|---|---|---|---|
|
0 events,
|
1 event,
Virtual Event
-
Virtual Event
The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) are co-sponsoring this public virtual workshop on August 30, 2022. All meeting materials—including agenda, panelist affiliations/disclosures, speaker slides, workshop recording, and transcript—will be posted here shortly before and/or after the completion of the workshop. The current state of development of pathogen-directed |
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
1 event,The 21st Presidential Advisory Council on Combating Antibiotic Resistant Bacteria (PACCARB) public meeting is tentatively being planned as an in-person event on September 12 and September 13, 2022. The meeting will focus on pandemic preparedness and AMR policy. Highlighted topics include: Understanding the Human Diagnostic Communication Network (Labs, Public Health Departments, and Providers) Infection Prevention |
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
|
0 events,
|
0 events,
|
2 events,
Virtual Event
The Scientific Advisory Committee on Alternative Toxicological Methods will meet 21-22 September 2022. This is a Save-the-Date posting. Further details will be made available at the National Toxicology Program website closer to the meeting date.
Virtual Event
-
Virtual Event
The U.S. Food and Drug Administration (FDA) will host a virtual town hall for monkeypox test developers on 21 September 2022. The purpose of these town halls is to help answer technical questions about the development and validation of tests for monkeypox. The FDA plays a critical role in protecting the United States from threats |
3 events,
Virtual Event
-
Virtual Event
The Vaccines and Related Biological Products Advisory Committee (VRBPAC) will convene on 22 September 2022 to discuss the Biologics License Application # 125739 (BLA - 125739) from Rebiotix Inc. for a product, Rebyota (Fecal Microbiota, Live), with a requested indication to “reduce the recurrence of Clostridioides difficile infection (CDI) in adults following antibiotic treatment for
Virtual Event
-
Virtual Event
Hear insights and information from APHIS and other experts on steps to take and what to expect during a bird flu outbreak during a free webinar on 22 September 2022. Learn from USDA and other experts about how to keep your flocks safe from highly pathogenic avian influenza (HPAI). This session is for enthusiasts, farmers, |
0 events,
|
0 events,
|
0 events,
|
2 events,The 5th Annual Meeting of the FDA/National Center for Toxicological Research (NCTR) – Massive Analysis and Quality Control Society (MAQC) 2022 Conference will be held September 26-27, 2022, at the U.S. FDA Headquarters, White Oak Campus in Silver Spring MD. Conference presentations, abstracts, and discussions will include themes around: Explainable/Reproducible AI/ML, AI/ML in health-related datasets,
-
The IARPA Pursuing Intelligent Complex Aerosols for Rapid Detection (PICARD) program will host a Proposer's Day on 26 September 2022 to introduce the PICARD program to potential proposers and to provide information on technical requirements and program objectives. The PICARD program intends to develop a fieldable sensing platform for the rapid identification of aerosol particles |
1 event,
Virtual Event
The goal of the Global Bioequivalence Harmonization Initiative (GBHI) conference is to offer the most informative and up to date science and regulation of bioequivalence in global drug development. The FDA AAPS EUFEPS 5th Annual GBHI Meeting will be held 28-29 September 2022. GBHI workshop provides an open forum for pharmaceutical scientists from academia, industry |
2 events,
Virtual Event
-
Virtual Event
The next public meeting of the National Biodefense Science Board (NBSB) will take place on Thursday, September 29. Join NBSB members, distinguished guests, federal leaders, and subject matter experts exploring topics such as how best to support rural and underserved communities during the COVID-19 pandemic, use of virtual healthcare during disasters, and health system operational |
0 events,
|
0 events,
|
0 events,
|
